Tissue Regenix Group PLC (TRX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
7.00p
Buy
7.50p
0.00p (+0.00%)
Prices updated at 22 Oct 2025, 13:24 BST
| Prices minimum 15 mins delay
Prices in GBX
Tissue Regenix Group PLC is a biotechnology company. Its business includes the development of regenerative products using its dcell technology.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 47.55 |
| 2023 | 49.32 |
| 2022 | 46.00 |
| 2021 | 42.93 |
| 2020 | 45.95 |
| 2019 | 46.18 |
| 2018 | 50.93 |
| 2017 | 49.80 |
| 2016 | 81.13 |
| 2015 | 68.00 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 0.25 |
| 2024 | 1.67 |
| 2023 | 1.74 |
| 2022 | 2.16 |
| 2021 | 2.69 |
| 2020 | 0.58 |
| 2019 | 1.01 |
| 2018 | 7.36 |
| 2017 | 57.87 |
| 2016 | 117.23 |
| 2015 | 292.81 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -1.61 |
| 2023 | -3.84 |
| 2022 | -5.84 |
| 2021 | -9.93 |
| 2020 | -27.60 |
| 2019 | -20.83 |
| 2018 | -18.95 |
| 2017 | -31.70 |
| 2016 | -51.41 |
| 2015 | -43.75 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.52 |
| 2023 | 1.43 |
| 2022 | 1.47 |
| 2021 | 1.35 |
| 2020 | 1.29 |
| 2019 | 1.21 |
| 2018 | 1.14 |
| 2017 | 1.15 |
| 2016 | 1.09 |
| 2015 | 1.09 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
